Logo image of BONHR.OL

BONHEUR ASA (BONHR.OL) Stock Fundamental Analysis

OSL:BONHR - Euronext Oslo - NO0003110603 - Common Stock - Currency: NOK

228  0 (0%)

Fundamental Rating

5

BONHR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 15 industry peers in the Industrial Conglomerates industry. Both the profitability and the financial health of BONHR get a neutral evaluation. Nothing too spectacular is happening here. BONHR is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BONHR had positive earnings in the past year.
In the past year BONHR had a positive cash flow from operations.
In multiple years BONHR reported negative net income over the last 5 years.
BONHR had a positive operating cash flow in 4 of the past 5 years.
BONHR.OL Yearly Net Income VS EBIT VS OCF VS FCFBONHR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B -2B 4B

1.2 Ratios

BONHR's Return On Assets of 4.75% is in line compared to the rest of the industry. BONHR outperforms 46.67% of its industry peers.
BONHR has a Return On Equity (15.13%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 10.18%, BONHR is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BONHR is in line with the industry average of 7.16%.
The 3 year average ROIC (8.67%) for BONHR is below the current ROIC(10.18%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.75%
ROE 15.13%
ROIC 10.18%
ROA(3y)1.89%
ROA(5y)-0.51%
ROE(3y)6.73%
ROE(5y)-2.71%
ROIC(3y)8.67%
ROIC(5y)N/A
BONHR.OL Yearly ROA, ROE, ROICBONHR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20

1.3 Margins

Looking at the Profit Margin, with a value of 8.17%, BONHR is doing worse than 60.00% of the companies in the same industry.
With a decent Operating Margin value of 18.35%, BONHR is doing good in the industry, outperforming 80.00% of the companies in the same industry.
In the last couple of years the Operating Margin of BONHR has grown nicely.
The Gross Margin of BONHR (80.04%) is better than 100.00% of its industry peers.
In the last couple of years the Gross Margin of BONHR has remained more or less at the same level.
Industry RankSector Rank
OM 18.35%
PM (TTM) 8.17%
GM 80.04%
OM growth 3YN/A
OM growth 5Y23.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5Y1.06%
BONHR.OL Yearly Profit, Operating, Gross MarginsBONHR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60 80

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BONHR is still creating some value.
BONHR has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for BONHR remains at a similar level compared to 5 years ago.
The debt/assets ratio for BONHR has been reduced compared to a year ago.
BONHR.OL Yearly Shares OutstandingBONHR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
BONHR.OL Yearly Total Debt VS Total AssetsBONHR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 1.86 indicates that BONHR is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.86, BONHR is doing worse than 66.67% of the companies in the same industry.
BONHR has a debt to FCF ratio of 4.09. This is a neutral value as BONHR would need 4.09 years to pay back of all of its debts.
BONHR has a Debt to FCF ratio of 4.09. This is amongst the best in the industry. BONHR outperforms 93.33% of its industry peers.
BONHR has a Debt/Equity ratio of 1.02. This is a high value indicating a heavy dependency on external financing.
BONHR has a worse Debt to Equity ratio (1.02) than 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 4.09
Altman-Z 1.86
ROIC/WACC1.38
WACC7.4%
BONHR.OL Yearly LT Debt VS Equity VS FCFBONHR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B 15B

2.3 Liquidity

BONHR has a Current Ratio of 1.66. This is a normal value and indicates that BONHR is financially healthy and should not expect problems in meeting its short term obligations.
BONHR has a Current ratio (1.66) which is comparable to the rest of the industry.
A Quick Ratio of 1.59 indicates that BONHR should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.59, BONHR is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1.59
BONHR.OL Yearly Current Assets VS Current LiabilitesBONHR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

3

3. Growth

3.1 Past

BONHR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.37%.
BONHR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.45%.
Measured over the past years, BONHR shows a quite strong growth in Revenue. The Revenue has been growing by 12.94% on average per year.
EPS 1Y (TTM)-4.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.37%
Revenue 1Y (TTM)15.45%
Revenue growth 3Y26.4%
Revenue growth 5Y12.94%
Sales Q2Q%12.82%

3.2 Future

Based on estimates for the next years, BONHR will show a very negative growth in Earnings Per Share. The EPS will decrease by -11.14% on average per year.
Based on estimates for the next years, BONHR will show a small growth in Revenue. The Revenue will grow by 1.87% on average per year.
EPS Next Y-1.74%
EPS Next 2Y-7.2%
EPS Next 3Y-11.14%
EPS Next 5YN/A
Revenue Next Year15.19%
Revenue Next 2Y4.46%
Revenue Next 3Y3.14%
Revenue Next 5Y1.87%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BONHR.OL Yearly Revenue VS EstimatesBONHR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B
BONHR.OL Yearly EPS VS EstimatesBONHR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 -10 20 -20

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.29, the valuation of BONHR can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of BONHR indicates a somewhat cheap valuation: BONHR is cheaper than 80.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of BONHR to the average of the S&P500 Index (29.35), we can say BONHR is valued rather cheaply.
A Price/Forward Earnings ratio of 9.27 indicates a reasonable valuation of BONHR.
BONHR's Price/Forward Earnings ratio is rather cheap when compared to the industry. BONHR is cheaper than 86.67% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BONHR to the average of the S&P500 Index (22.10), we can say BONHR is valued rather cheaply.
Industry RankSector Rank
PE 8.29
Fwd PE 9.27
BONHR.OL Price Earnings VS Forward Price EarningsBONHR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BONHR is valued cheaper than 93.33% of the companies in the same industry.
BONHR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BONHR is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.22
EV/EBITDA 3.38
BONHR.OL Per share dataBONHR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300

4.3 Compensation for Growth

BONHR's earnings are expected to decrease with -11.14% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.2%
EPS Next 3Y-11.14%

4

5. Dividend

5.1 Amount

BONHR has a Yearly Dividend Yield of 2.96%.
BONHR's Dividend Yield is comparable with the industry average which is at 3.70.
Compared to an average S&P500 Dividend Yield of 2.33, BONHR pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.96%

5.2 History

The dividend of BONHR is nicely growing with an annual growth rate of 37.75%!
Dividend Growth(5Y)37.75%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

BONHR pays out 40.77% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP40.77%
EPS Next 2Y-7.2%
EPS Next 3Y-11.14%
BONHR.OL Yearly Income VS Free CF VS DividendBONHR.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B -2B 4B
BONHR.OL Dividend Payout.BONHR.OL Dividend Payout, showing the Payout Ratio.BONHR.OL Dividend Payout.PayoutRetained Earnings

BONHEUR ASA

OSL:BONHR (3/7/2025, 7:00:00 PM)

228

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)02-14 2025-02-14
Earnings (Next)05-09 2025-05-09
Inst Owners29.9%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap9.70B
Analysts86.15
Price Target313.14 (37.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.96%
Yearly Dividend23.62
Dividend Growth(5Y)37.75%
DP40.77%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)64.73%
Min EPS beat(2)9.88%
Max EPS beat(2)119.58%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)14.64%
Min Revenue beat(2)4.17%
Max Revenue beat(2)25.12%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.22%
PT rev (3m)0.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.49%
EPS NY rev (1m)0.09%
EPS NY rev (3m)6.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.15%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)1.05%
Valuation
Industry RankSector Rank
PE 8.29
Fwd PE 9.27
P/S 0.68
P/FCF 4.22
P/OCF 2.8
P/B 1.26
P/tB 1.5
EV/EBITDA 3.38
EPS(TTM)27.5
EY12.06%
EPS(NY)24.59
Fwd EY10.78%
FCF(TTM)54.08
FCFY23.72%
OCF(TTM)81.42
OCFY35.71%
SpS336.28
BVpS181.66
TBVpS152.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.75%
ROE 15.13%
ROCE 13.88%
ROIC 10.18%
ROICexc 15.12%
ROICexgc 16.76%
OM 18.35%
PM (TTM) 8.17%
GM 80.04%
FCFM 16.08%
ROA(3y)1.89%
ROA(5y)-0.51%
ROE(3y)6.73%
ROE(5y)-2.71%
ROIC(3y)8.67%
ROIC(5y)N/A
ROICexc(3y)12.35%
ROICexc(5y)N/A
ROICexgc(3y)13.64%
ROICexgc(5y)N/A
ROCE(3y)12.14%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y32.09%
ROICexc growth 3YN/A
ROICexc growth 5Y32.56%
OM growth 3YN/A
OM growth 5Y23.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5Y1.06%
F-Score6
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 4.09
Debt/EBITDA 2.06
Cap/Depr 96.24%
Cap/Sales 8.13%
Interest Coverage 3.99
Cash Conversion 90.37%
Profit Quality 196.75%
Current Ratio 1.66
Quick Ratio 1.59
Altman-Z 1.86
F-Score6
WACC7.4%
ROIC/WACC1.38
Cap/Depr(3y)79.6%
Cap/Depr(5y)84.74%
Cap/Sales(3y)9.12%
Cap/Sales(5y)13.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.37%
EPS Next Y-1.74%
EPS Next 2Y-7.2%
EPS Next 3Y-11.14%
EPS Next 5YN/A
Revenue 1Y (TTM)15.45%
Revenue growth 3Y26.4%
Revenue growth 5Y12.94%
Sales Q2Q%12.82%
Revenue Next Year15.19%
Revenue Next 2Y4.46%
Revenue Next 3Y3.14%
Revenue Next 5Y1.87%
EBIT growth 1Y-2.84%
EBIT growth 3YN/A
EBIT growth 5Y39.61%
EBIT Next Year57.02%
EBIT Next 3Y18.31%
EBIT Next 5YN/A
FCF growth 1Y103.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y32.41%
OCF growth 3YN/A
OCF growth 5Y62.62%